NEVRO CORP.: interest expense

What this measure means

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Exact concept: us-gaap:InterestExpense. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2014-01-01 to 2023-12-31. The SEC response was captured on 2026-09-21.

This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.

Selected filing history

Related financial histories

• NEVRO CORP.: total assets
• NEVRO CORP.: total liabilities
• NEVRO CORP.: stockholders equity
• NEVRO CORP.: cash and cash equivalents
• NEVRO CORP.: net income or loss
• NEVRO CORP.: operating cash flow
• NEVRO CORP.: capital expenditure payments
• NEVRO CORP.: revenue
• NEVRO CORP.: contract revenue excluding tax
• NEVRO CORP.: financing cash flow
• NEVRO CORP.: investing cash flow
• NEVRO CORP.: retained earnings or deficit
• NEVRO CORP.: basic weighted-average shares
• NEVRO CORP.: diluted weighted-average shares
• NEVRO CORP.: basic earnings per share
• NEVRO CORP.: diluted earnings per share
• NEVRO CORP.: income tax expense or benefit
• NEVRO CORP.: net property, plant and equipment
• NEVRO CORP.: share-based compensation expense
• NEVRO CORP.: operating income or loss
• NEVRO CORP.: current assets
• NEVRO CORP.: current liabilities
• NEVRO CORP.: current accounts payable
• NEVRO CORP.: goodwill carrying amount
• NEVRO CORP.: net current accounts receivable
• NEVRO CORP.: operating expenses
• NEVRO CORP.: net inventory
• NEVRO CORP.: gross profit
• NEVRO CORP.: cost of revenue
• NEVRO CORP.: selling, general and administrative expense
• NEVRO CORP.: research and development expense
• NEVRO CORP.: common shares outstanding
• NEVRO CORP.: cash including restricted cash
• NEVRO CORP.: accumulated other comprehensive income or loss
• NEVRO CORP.: operating lease right-of-use asset
• NEVRO CORP.: operating lease liability
• NEVRO CORP.: long-term debt
• NEVRO CORP.: gross property, plant and equipment
• NEVRO CORP.: accumulated depreciation on property, plant and equipment
• NEVRO CORP.: other noncurrent assets
• NEVRO CORP.: other noncurrent liabilities
• NEVRO CORP.: accrued current liabilities
• NEVRO CORP.: prepaid expenses and other current assets
• NEVRO CORP.: net deferred tax assets
• NEVRO CORP.: pre-tax income or loss from continuing operations
• NEVRO CORP.: profit or loss including noncontrolling interests
• NEVRO CORP.: comprehensive income or loss
• NEVRO CORP.: net income available to common stockholders
• NEVRO CORP.: depreciation expense
• NEVRO CORP.: depreciation, depletion and amortization
• NEVRO CORP.: amortization of intangible assets
• NEVRO CORP.: nonoperating interest expense
• NEVRO CORP.: other nonoperating income or expense
• NEVRO CORP.: current income tax expense or benefit
• NEVRO CORP.: deferred income tax expense or benefit
• NEVRO CORP.: interest paid, net
• NEVRO CORP.: income taxes paid, net
• NEVRO CORP.: operating lease payments
• NEVRO CORP.: change in accounts receivable
• NEVRO CORP.: change in inventories
• NEVRO CORP.: change in accounts payable

Inspect the source

Entity

NEVRO CORP. / CIK 0001444380

Captured

2026-09-21T17:19:58.092Z

SEC response SHA-256

0c2e1e0ea07fd5aa62ea822db0f1b0aba69fb5f3183a6c9ec8f3e0eef0586d49

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001444380.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))